Video

Improving Treatment for Pediatric Cardiomyopathy

Author(s):

Recent research shows that advances in treatment are leading to improved survival rates for children with dilated cardiomyopathy, even among those patients who do not receive a heart transplant.

Recent research shows that advances in treatment are leading to improved survival rates for children with dilated cardiomyopathy, even among those patients who do not receive a heart transplant.

Rakesh Singh, MD, MS, discussed some of these new developments in treatment during the 2014 American Heart Association Scientific Sessions in Chicago.

Related Videos
New ‘Level Up’ Data on Upadacitinib (Rinvoq) for Atopic Dermatitis, with Christopher Bunick, MD, PhD
Julie Refardt, MD, PhD: Current Hyponatremia Clinical Interventions Sufficient
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
Christopher Bunick, MD, PhD: Facts About Systemic Therapies’ Safety, Mechanism of Action
Carla Nester, MD | Credit: HCPLive
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
Will Herrington, MBBS, MD, MA: Empagliflozin Follow-up Data Informs Clinical Care for CKD
Jennifer Lai Yee, MD, PhD, MPH: Honing in on Sparsentan’s Benefit in Genetic FSGS
Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO
Ladan Zand, MD: Obinutuzumab Promising Option for Refractory, Primary FSGS
© 2024 MJH Life Sciences

All rights reserved.